CMND
NASDAQ · Pharmaceuticals
Clearmind Medicine Inc
$1.66
-0.09 (-5.14%)
Open$1.75
Previous Close$1.75
Day High$1.76
Day Low$1.58
52W High$524.00
52W Low—
Volume—
Avg Volume138.4K
Market Cap2.43M
P/E Ratio—
EPS$-544.74
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 523.5K | 483.3K | 576.6K |
| Net Income | 68.9K | 73.1K | 95.7K |
| Profit Margin | 13.2% | 15.1% | 16.6% |
| EBITDA | 118.6K | 102.7K | 135.6K |
| Free Cash Flow | 93.6K | 59.2K | 119.0K |
| Rev Growth | +19.2% | +7.8% | +18.0% |
| Debt/Equity | 0.43 | 0.45 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |